Boomerang Pharmaceutical Communications - Ownership and Business Overview

MarketingCompany

Boomerang Pharmaceutical Communications Ownership

Who owns Boomerang Pharmaceutical Communications?

Boomerang Pharmaceutical Communications is owned by Accenture. It was acquired on December 10, 2015.

Boomerang Pharmaceutical Communications Business Overview

Where is Boomerang Pharmaceutical Communications headquartered?

Boomerang Pharmaceutical Communications is headquartered in Parsippany, New Jersey.

What sector is Boomerang Pharmaceutical Communications in?

Boomerang Pharmaceutical Communications is a marketing company.

Marketing M&A Summary in 2015

Out of 60 sectors in the Mergr database, marketing ranked 17 in number of deals in 2015. The largest marketing acquisition in 2015 was Infront Sports & Media AG - which was acquired by Dalian Wanda Group Co for $1.2B.

Join Mergr to view all 163 acquisitions of marketing companies in 2015, including 17 acquisitions by private equity firms, and 146 by strategics.

Boomerang Pharmaceutical Communications

14 Walsh Drive,
Parsippany, New Jersey 07054
United States,
(973) 265-8319
www.boomerangpharma.com

Boomerang Pharmaceutical Communications is a full services digital marketing agency serving the pharmaceutical, biotech and medical-device industries.


 Subscribe to unlock this and 201,888
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.